171 related articles for article (PubMed ID: 34010327)
21. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
22. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.
Cohen AL; Wenger JB; James-Todd T; Lamparello BM; Halprin E; Serdy S; Fan S; Horowitz GL; Lim KH; Rana S; Takoudes TC; Wyckoff JA; Thadhani R; Karumanchi SA; Brown FM
Hypertens Pregnancy; 2014 Feb; 33(1):81-92. PubMed ID: 24354578
[TBL] [Abstract][Full Text] [Related]
23. Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders.
Engels T; Pape J; Schoofs K; Henrich W; Verlohren S
Hypertens Pregnancy; 2013 Nov; 32(4):459-73. PubMed ID: 23957293
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?
Moe K; Heidecke H; Dechend R; Staff AC
Pregnancy Hypertens; 2017 Oct; 10():83-89. PubMed ID: 29153696
[TBL] [Abstract][Full Text] [Related]
25. Association of angiotensinogen gene polymorphisms and angiogenic factors with preeclampsia in Chinese women.
Song C; Xie S; Wang J; Lian J; Diao B; Tang Y
Gynecol Obstet Invest; 2013; 76(1):64-8. PubMed ID: 23860016
[TBL] [Abstract][Full Text] [Related]
26. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
[TBL] [Abstract][Full Text] [Related]
27. Serum sFlt-1/PlGF ratio has better diagnostic ability in early- compared to late-onset pre-eclampsia.
Chuah TT; Tey WS; Ng MJ; Tan ETH; Chern B; Tan KH
J Perinat Med; 2018 Dec; 47(1):35-40. PubMed ID: 29708884
[TBL] [Abstract][Full Text] [Related]
28. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
29. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy.
Palm M; Basu S; Larsson A; Wernroth L; Åkerud H; Axelsson O
Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1244-51. PubMed ID: 21568945
[TBL] [Abstract][Full Text] [Related]
30. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
[TBL] [Abstract][Full Text] [Related]
31. Angiogenic biomarkers in triage and risk for preeclampsia with severe features.
Rana S; Salahuddin S; Mueller A; Berg AH; Thadhani RI; Karumanchi SA
Pregnancy Hypertens; 2018 Jul; 13():100-106. PubMed ID: 30177034
[TBL] [Abstract][Full Text] [Related]
32. The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16-20 Weeks Gestation.
Benovská M; Opluštilová A; Pinkavová J; Hodická Z; Cermáková Z
Lab Med; 2018 Mar; 49(2):112-117. PubMed ID: 29267975
[TBL] [Abstract][Full Text] [Related]
33. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
[TBL] [Abstract][Full Text] [Related]
34. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
35. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.
Lou WZ; Jiang F; Hu J; Chen XX; Song YN; Zhou XY; Liu JT; Bian XM; Gao JS
Dis Markers; 2019; 2019():6270187. PubMed ID: 31396294
[TBL] [Abstract][Full Text] [Related]
36. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
Bian Z; Shixia C; Duan T
PLoS One; 2015; 10(4):e0124684. PubMed ID: 25906026
[TBL] [Abstract][Full Text] [Related]
37. Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension.
Heimberger S; Mueller A; Ratnaparkhi R; Perdigao JL; Rana S
Pregnancy Hypertens; 2020 Apr; 20():124-130. PubMed ID: 32299059
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of soluble fms-like tyrosine kinase-1 against placental growth factor for preeclampsia in a Chinese pregnant women population.
Yu F; Bai Q; Zhang S; Jiang Y
J Clin Lab Anal; 2019 Jun; 33(5):e22861. PubMed ID: 30758082
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.
Kleinrouweler CE; Wiegerinck MM; Ris-Stalpers C; Bossuyt PM; van der Post JA; von Dadelszen P; Mol BW; Pajkrt E;
BJOG; 2012 Jun; 119(7):778-87. PubMed ID: 22433027
[TBL] [Abstract][Full Text] [Related]
40. Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction.
Gaccioli F; Sovio U; Gong S; Cook E; Charnock-Jones DS; Smith GCS
Hypertension; 2023 Feb; 80(2):325-334. PubMed ID: 35866422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
